Cancer Letters

Cancer Letters

Volume 378, Issue 1, 1 August 2016, Pages 59-67
Cancer Letters

Original Articles
miR-1236 regulates hypoxia-induced epithelial–mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3

https://doi.org/10.1016/j.canlet.2016.05.006Get rights and content

Highlights

  • MiR-1236 represses SENP1 and HDAC3.

  • MiR-1236 is crucial for hypoxia-induced EMT.

  • MiR-1236 is repressed by Twist1.

Abstract

Intratumoral hypoxia induces epithelial–mesenchymal transition and promotes cancer metastasis. MicroRNAs (miRNAs) are endogenous, single-strand RNA molecules that regulate gene expression. MiRNAs control cell growth, proliferation, differentiation and cell death and may function as oncogenes or tumor suppressors. HDAC3 and SENP1 are two molecules involved in hypoxia-induced EMT and HIF-1α stability, respectively. In this report, we show that miR-1236 plays a critical role in hypoxia-induced EMT and metastasis. MiRNA prediction programs TargetScan and miRanda show that miR-1236 may target HDAC3 and SENP1. MiR-1236 represses the luciferase activity of reporter constructs containing 3'UTR of HDAC3 and SENP1 as well as the expression levels of HDAC3 and SENP1. MiR-1236 abolishes hypoxia-induced EMT and inhibits migration and invasion activity of tumor cells. Hypoxia represses miR-1236 expression. The promoter region of miR-1236 is identified as the NELFE promoter. Twist1, an EMT regulator activated by hypoxia/HIF-1α, is shown to repress the reporter construct driven by the NELFE promoter. The binding site of Twist1 in the NELFE promoter is identified and chromatin immunoprecipitation assays show the direct binding of Twist1 to this site. Overexpression or knockdown of Twist1 in stable cell lines shows the inverse correlation between Twist1 and miR-1236 expression. These results identify a miRNA that regulates hypoxia-induced EMT and metastasis through repressing HDAC3 and SENP1 expression and present a regulatory network that involves many key players in hypoxia-induced EMT.

Introduction

Intratumoral hypoxia is one of the crucial events that mediate cancer metastasis [1], [2]. Hypoxia induces epithelial–mesenchymal transition (EMT), a critical process involved in development and tumor progression [3], [4]. EMT is a process whereby epithelial cell layers lose polarity and cell–cell contact and undergo a dramatic remodeling of cytoskeleton to increase cell migration and invasion activity [3], [4]. EMT is usually mediated by transcriptional regulators, including Snail, Slug, Twist1, ZEB1, ZEB2, etc [3], [4], [5]. Interestingly, these EMT transcriptional regulators are also regulated by hypoxia/hypoxia-inducible factor 1α (HIF-1α) [5], [6].

Hypoxia-induced EMT can occur through various epigenetic mechanisms [7], [8]. One of the important mechanisms is through the interplay between HDAC3 and WDR5 to regulate EMT marker gene (i.e. E-cadherin, vimentin, etc) expression [9]. HDAC3 removes the acetyl group of histone 3 lysine 4 (H3K4Ac) to facilitate the repression of epithelial gene and activation of mesenchymal gene expression [8], [9]. Knockdown of HDAC3 abolishes hypoxia-induced EMT marker gene regulation [8], [9]. HDAC3 obviously plays an important role in hypoxia-induced EMT. SUMO-specific protease 1 (SENP1) reverses the sumolyation of HIF-1α to prevent its ubiquitination and degradation [10]. SENP1 plays a critical role in the stabilization of HIF-1α [10].

MicroRNAs (miRNAs) are 18–24 nucleotide noncoding RNA molecules that regulate gene expression at various levels [11]. MiRNAs may have oncogene or tumor suppressor property depending on their targets [11], [12]. Various miRNAs have been shown to be involved in EMT [12]. Hypoxia/HIF-1α regulates various miRNAs to mediate tumor progression, induce drug resistance, and regulate tumor cell lysis by cytotoxic T cells [13], [14], [15], [16].

MicroRNA miR-1236 is an intronic miRNA (102 bp in size) that is located in chromosome 6p. MiR-1236-3p is the major form and there is no other family member (GeneCards and miRBase database). MiR-1236 and Negative Elongation Factor E (NELFE) share the same promoter and miR-1236 co-expresses with NELFE [17], [18]. MiR-1236 is found only in human, Pan troglodytes and Pongo pygmaeus (GeneCards and miRBase database). MicroRNA miR-1236 has been shown to repress VEGFR-3, α-fetoprotein, VprBP, RORγ, p21 promoter, and ZEB1 to inhibit inflammatory lymphangiogenesis, PI3K/Akt pathway, HIV-1 infection, ulcerative colitis, cell proliferation, or cell migration/invasion, respectively [19], [20], [21], [22], [23], [24]. MiR-1236 has been shown to be induced by IL-1β [19]. MiRNAs that regulate HDAC3 or SENP1 have been identified [25], [26]. However, whether a single miRNA can simultaneously regulate SENP1 and HDAC3 remains to be discovered.

In this study, we show that miR-1236 regulates EMT and cancer cell migration and invasion by simultaneously repressing HDAC3 and SENP1 expression. Due to the ability of SENP1 to stabilize HIF-1α, repression of miR-1236 during hypoxia causes abolishment of SENP1 inhibition and leads to increased HIF-1α levels. We also show that Twist1 represses the expression of miR-1236 by direct binding to the promoter region of miR-1236. We show that miR-1236 expression is repressed by Twist1 under hypoxia, which activates the levels of HDAC3 and SENP1 and contributes to EMT and cancer metastasis induced by hypoxia.

Section snippets

Cell lines and oxygen deprivation

Human breast cancer (MCF7), lung cancer (H1299), head and neck cancer (SAS) and embryonic kidney (293T) cell lines have been described previously [6], [9]. The H1299-miR-1236 and MCF7-miR-1236 cell lines were generated by transfecting the pMcherry-miR-1236 plasmid into H1299 and MCF7 cells followed by puromycin (2 µg/ml) selection. The H1299-Cont. and MCF7-Cont. cell lines were generated by transfecting the pmR-mcherry plasmid into H1299 and MCF7 cells followed by puromycin (2 µg/ml) selection.

Identification of miR-1236 that regulates HDAC3 through a bioinformatics approach

HDAC3 has been shown to play a critical role in hypoxia-mediated epithelial–mesenchymal transition [9]. However, the miRNAs that can regulate HDAC3 remain unknown. In order to identify the miRNAs that regulate HDAC3 and further investigate the functions of the HDAC3-regulating miRNAs, we first used the prediction programs “Targetscan” and “miRanda” to search for the miRNAs that possibly target HDAC3. Through the intersection of Targetscan and miRanda results, eight miRNAs that possibly target

Discussion

Hypoxia-induced epithelial–mesenchymal transition (EMT) plays a crucial role in cancer metastasis induced by intratumoral hypoxia [2], [6], [9]. Epigenetic mechanisms that regulate hypoxia-induced EMT have been reviewed [7], [8], [9]. However, microRNAs that could regulate hypoxia-induced EMT are largely unknown except a few hypoxia-induced microRNAs that were shown to mediate cancer metastasis, induce drug resistance, and regulate tumor cells lysis by cytotoxic T cells [13], [14], [15], [16].

Funding

This work was supported in part to K.J.W. by Ministry of Science and Technology Summit grant (MOST 104-2745-B-039-001-ASP), Center of Excellence for Cancer Research at Taipei Veterans General Hospital (MOHW105-TDU-B-211-134-003), and National Health Research Institutes (NHRI-EX104-10230SI).

Authors' contributions

KJW conceived and designed the experiments. SYC performed the experiments. KJW, SCT, and THC analyzed the data and provided input to the project. KJW wrote the manuscript.

Conflict of interest

All of the authors of this paper declare that they have no conflict of interest.

References (31)

  • J.H. Tsai et al.

    Epithelial-mesenchymal plasticity in carcinoma metastasis

    Genes Dev

    (2013)
  • M.H. Yang et al.

    TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development

    Cell Cycle

    (2008)
  • M.H. Yang et al.

    Direct regulation of TWIST by HIF-1alpha promotes metastasis

    Nat. Cell Biol

    (2008)
  • Y.P. Tsai et al.

    Epigenetic regulation of hypoxia-responsive gene expression: focusing on chromatin and DNA modifications

    Int. J. Cancer

    (2014)
  • A. Lujambio et al.

    The microcosmos of cancer

    Nature

    (2012)
  • Cited by (43)

    • miR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer

      2022, Archives of Medical Research
      Citation Excerpt :

      MiRs have also a vital function in cell development, proliferation, differentiation, and death, through interactions with their target genes (19). Previous studies revealed that miR-1236 (20), miR-132-3p (21), miR-326 (22), and miR-193b-3p (23) target the 3′-UTR of HDAC3 mRNA. We performed an in-detailed bioinformatics analysis and found that miR-589-5p potentially targets HDAC3.

    • HDAC3 protects against atherosclerosis through inhibition of inflammation via the microRNA-19b/PPARγ/NF-κB axis

      2021, Atherosclerosis
      Citation Excerpt :

      Moreover, HDAC3 has been found to inhibit the onset of AS by promoting endothelial cell survival [9]. In addition, numerous studies have indicated that HDAC3 is capable of regulating the expression of certain microRNAs (miRNAs) [10,11], which are small non-coding RNAs with the ability to modulate gene expression at the post-transcriptional level [12]. Studies have also shown the crucial roles of miRNAs in the initiation and progression of human diseases, acting either as oncogenes or as tumor suppressors, representing novel therapeutic agents [13].

    • Hypoxia-induced epithelial to mesenchymal transition in cancer

      2020, Cancer Letters
      Citation Excerpt :

      Hypoxia induction of EMT required downregulation of miR-34A, and ectopic expression of miR-34A inhibited the transition process [131]. Hypoxia similarly repressed miR-1236 through a TWIST-mediated pathway, while ectopic expression of the miRNA abolished hypoxia-induced EMT [132]. Although several examples exist whereby hypoxia regulates EMT by downregulating miRNA, upregulation of miR-210 in the hypoxic niche causes suppression of E-cadherin and promotes EMT [133].

    View all citing articles on Scopus
    View full text